Development and validation of a prediction model for opioid use disorder among youth

•Prognostic models can help identify adolescents at risk for opioid use.•A simple prognostic model was developed and validated in two health systems.•This model identified adolescents age 14–18 at risk for OUD within 3.5 years.•The model could be used to target prevention efforts in health systems....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol dependence 2021-10, Vol.227, p.108980-108980, Article 108980
Hauptverfasser: Wagner, Nicole M., Binswanger, Ingrid A., Shetterly, Susan M., Rinehart, Deborah J., Wain, Kris F., Hopfer, Christian, Glanz, Jason M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Prognostic models can help identify adolescents at risk for opioid use.•A simple prognostic model was developed and validated in two health systems.•This model identified adolescents age 14–18 at risk for OUD within 3.5 years.•The model could be used to target prevention efforts in health systems. Youth are vulnerable to opioid use initiation and its complications. With growing rates of opioid overdose, strategies to identify youth at risk of opioid use disorder (OUD) to efficiently focus prevention interventions are needed. This study developed and validated a prediction model of OUD in youth aged 14−18 years. The model was developed in a Colorado healthcare system (derivation site) using Cox proportional hazards regression analysis. Model predictors and outcomes were identified using electronic health record data. The model was externally validated in a separate Denver safety net health system (validation site). Youth were followed for up to 3.5 years. We evaluated internal and external validity using discrimination and calibration. The derivation cohort included 76,603 youth, of whom 108 developed an OUD diagnosis. The model contained 3 predictors (smoking status, mental health diagnosis, and non-opioid substance use or disorder) and demonstrated good calibration (p = 0.90) and discrimination (bootstrap-corrected C-statistic = 0.76: 95 % CI = 0.70, 0.82). Sensitivity and specificity were 57 % and 84 % respectively with a positive predictive value (PPV) of 0.49 %. The validation cohort included 45,790 youth of whom, 74 developed an OUD diagnoses. The model demonstrated poorer calibration (p 
ISSN:0376-8716
1879-0046
DOI:10.1016/j.drugalcdep.2021.108980